We are live on ! Find out more
GSK icon

GSK
GSK

1,035 hedge funds and large institutions have $20.7B invested in GSK in 2026 Q1 according to their latest regulatory filings, with 142 funds opening new positions, 315 increasing their positions, 381 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 142 | Existing positions closed: 83

63% more call options, than puts

Call options by funds: $222M | Put options by funds: $137M

36% more funds holding in top 10

Funds holding in top 10: 11 → 15 (+4)

5% more capital invested

Capital invested by funds: $19.6B → $20.7B (+$1.03B)

4% more funds holding

Funds holding: 996 → 1,035 (+39)

1.11% less ownership

Funds ownership: 19.53% → 18.42% (-1.1%)

17% less repeat investments, than reductions

Existing positions increased: 315 | Existing positions reduced: 381

Holders
1,035
Holders Change
+39
Holders Change %
+3.92%
% of All Funds
12.67%
Holding in Top 10
15
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+36.36%
% of All Funds
0.18%
New
142
Increased
315
Reduced
381
Closed
83
Calls
$222M
Puts
$137M
Net Calls
+$85.7M
Net Calls Change
-$49.4M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$282M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$154M
3
Goldman Sachs
Goldman Sachs
New York
+$127M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$111M
5
BlackRock
BlackRock
New York
+$94.1M

Top Sellers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
-$534M
2
JEST
JTC Employer Solutions Trustee
Jersey
-$292M
3
UBS Group
UBS Group
Switzerland
-$227M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$145M
5
Holocene Advisors
Holocene Advisors
New York
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1001
Corsicana & Co
Texas
$3.87K – – –
SFS
1002
Sunrise Financial Services
Washington
$3.75K – – –
TSMHT
1003
Thurston Springer Miller Herd & Titak
Indiana
$3.31K – – –
GWM
1004
Gilpin Wealth Management
Colorado
$3.26K – – –
APW
1005
Aventura Private Wealth
Florida
$3.26K – – –
KFA
1006
Kelleher Financial Advisors
New York
$3.26K – – –
NF
1007
Napier Financial
Massachusetts
$3.2K +$3.14K +58 New
BSB
1008
Bangor Savings Bank
Maine
$3.15K -$34.4K -634 -92%
WA
1009
WPG Advisers
Maryland
$3.15K -$867 -16 -22%
BAM
1010
Byrne Asset Management
New Jersey
$3.09K – – –
NWS
1011
Nvest Wealth Strategies
Ohio
$2.98K +$325 +6 +13%
JFG
1012
JDM Financial Group
Texas
$2.87K +$2.82K +52 New
MSG
1013
Main Street Group
Virginia
$2.76K +$2.71K +50 New
SIS
1014
Strategic Investment Solutions
Illinois
$2.59K – – –
WA
1015
Westfuller Advisors
New York
$2.28K -$975 -18 -31%
VWA
1016
Valued Wealth Advisors
Utah
$2.04K +$2K +37 New
LAS
1017
Lloyd Advisory Services
Georgia
$1.99K -$146K -2,689 -99%
DWM
1018
Dogwood Wealth Management
Kansas
$1.99K +$1.95K +36 New
KFG
1019
Kingdom Financial Group
Arizona
$1.99K +$1.95K +36 New
AFC
1020
Ares Financial Consulting
California
$1.9K – – –
ECA
1021
Elevated Capital Advisors
Utah
$1.88K – – –
HIW
1022
Holos Integrated Wealth
Pennsylvania
$1.79K – – –
SIM
1023
Synergy Investment Management
Florida
$1.66K +$1.63K +30 New
RJA
1024
Ross\Johnson & Associates
Minnesota
$1.32K – – –
FFA
1025
Frazier Financial Advisors
Ohio
$1.16K -$3.2K -59 -74%
39 40
41
42 43

GSK Hedge Fund Activity: Q1 2026 in Review

1,035 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2026, worth a combined $20.7B — up 5.3% from $19.6B a quarter earlier.

Buyers outnumbered sellers: 142 funds opened new GSK positions and 83 closed out — a net gain of 59 holders — while 315 added to existing stakes and 381 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $282M. The largest seller was Dodge & Cox, cutting an estimated $534M.

  • 1,035 institutional investors held GSK (GSK) as of Q1 2026, up from 996 in Q4 2025.
  • Funds reported $20.7B of GSK stock for Q1 2026, up 5.3% quarter-over-quarter.
  • 142 funds opened new GSK positions in Q1 2026 and 83 closed out, a net change of +59 holders.
  • The largest GSK buyer in Q1 2026 was Morgan Stanley, an estimated $282M added.
  • The largest GSK seller in Q1 2026 was Dodge & Cox, an estimated $534M sold.

Based on aggregated 13F filings for Q1 2026.